Maternal obesity increases hypothalamic miR-505-5p expression in mouse offspring leading to altered fatty acid sensing and increased intake of high-fat food.


Journal

PLoS biology
ISSN: 1545-7885
Titre abrégé: PLoS Biol
Pays: United States
ID NLM: 101183755

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 13 09 2023
accepted: 25 04 2024
medline: 4 6 2024
pubmed: 4 6 2024
entrez: 4 6 2024
Statut: epublish

Résumé

In utero exposure to maternal obesity programs increased obesity risk. Animal models show that programmed offspring obesity is preceded by hyperphagia, but the mechanisms that mediate these changes are unknown. Using a mouse model of maternal obesity, we observed increased intake of a high-fat diet (HFD) in offspring of obese mothers that precedes the development of obesity. Through small RNA sequencing, we identified programmed overexpression of hypothalamic miR-505-5p that is established in the fetus, lasts to adulthood and is maintained in hypothalamic neural progenitor cells cultured in vitro. Metabolic hormones and long-chain fatty acids associated with obesity increase miR-505-5p expression in hypothalamic neurons in vitro. We demonstrate that targets of miR-505-5p are enriched in fatty acid metabolism pathways and overexpression of miR-505-5p decreased neuronal fatty acid metabolism in vitro. miR-505-5p targets are associated with increased BMI in human genetic studies. Intra-cerebroventricular injection of miR-505-5p in wild-type mice increased HFD intake, mimicking the phenotype observed in offspring exposed to maternal obesity. Conversely, maternal exercise intervention in an obese mouse pregnancy rescued the programmed increase of hypothalamic miR-505-5p in offspring of obese dams and reduced HFD intake to control offspring levels. This study identifies a novel mechanism by which maternal obesity programs obesity in offspring via increased intake of high-fat foods.

Identifiants

pubmed: 38833481
doi: 10.1371/journal.pbio.3002641
pii: PBIOLOGY-D-23-02375
doi:

Substances chimiques

MicroRNAs 0
Fatty Acids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3002641

Informations de copyright

Copyright: © 2024 Dearden et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Laura Dearden (L)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Metabolic Diseases Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

Isadora C Furigo (IC)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Metabolic Diseases Unit, Institute of Metabolic Science, Cambridge, United Kingdom.
Universidade de Sao Paulo, Instituto de Ciencias Biomedicas, Departamento de Fisiologia e Biofisica, Sao Paulo, Brazil.
Centre for Health and Life Sciences, Coventry University, Coventry, United Kingdom.

Lucas C Pantaleão (LC)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Metabolic Diseases Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

L W P Wong (LWP)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Metabolic Diseases Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

Denise S Fernandez-Twinn (DS)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Metabolic Diseases Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

Juliana de Almeida-Faria (J)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Metabolic Diseases Unit, Institute of Metabolic Science, Cambridge, United Kingdom.
University of Campinas, Faculty of Medical Sciences, Department of Pharmacology, Campinas, Brazil.

Katherine A Kentistou (KA)

MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

Maria V Carreira (MV)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Metabolic Diseases Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

Guillaume Bidault (G)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Metabolic Diseases Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

Antonio Vidal-Puig (A)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Metabolic Diseases Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

Ken K Ong (KK)

MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

John R B Perry (JRB)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

Jose Donato (J)

Universidade de Sao Paulo, Instituto de Ciencias Biomedicas, Departamento de Fisiologia e Biofisica, Sao Paulo, Brazil.

Susan E Ozanne (SE)

University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, United Kingdom.
MRC Metabolic Diseases Unit, Institute of Metabolic Science, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH